| Literature DB >> 23011024 |
Abstract
During tumorigenesis cancer cells acquire certain features allowing for sustained growth and circumvention of programmed cell death. For decades cancer research has been focused on the molecular mechanisms of apoptosis and how to overcome apoptosis resistance in tumor cells. Meanwhile, novel types of programmed cell death have turned out to be important for both physiological and pathological processes. Recent findings imply that induction of alternative forms of programmed cell death, such as necroptosis, might be used as a therapeutic approach to overcome therapy resistance in cancer.Entities:
Mesh:
Year: 2012 PMID: 23011024 DOI: 10.1007/s00292-012-1678-5
Source DB: PubMed Journal: Pathologe ISSN: 0172-8113 Impact factor: 1.011